Freespira CEO Dean Sawyer said its FDA cleared digital therapeutic is the first that’s proven to significantly reduce or eliminate…
Former Blue Cross Blue Shield Health Plan chief medical officer and chief healthcare strategist brings clinical, quality and business insights…
Platinum award recognizes Freespira’s ground-breaking treatment providing relief for patients with panic attacks, panic disorder, and post-traumatic stress disorder KIRKLAND,…
We’ve long known that the coronavirus pandemic would dramatically impact the mental health of health care professionals and the general…
Study in Journal of Mental Health and Clinic Psychology Confirms Freespira Drastically Reduces Panic Disorder Severity KIRKLAND, Wash., April 28, 2021…
Market Watch | March 17, 2021 ‘Although serious illness from COVID-19 is uncommon among teens, the changes brought on by…
Former Livongo, 23andMe, Allscripts, Healthways and LabCorp leader brings unique expertise to digital therapeutic company PR Newswire | March 16th,…
Freespira was recently praised as having ‘enormous promise’ is a recent blog from industry expert Lisa Suennan. In her blog…
Freespira, Inc. was recently featured in Next Steps for Digital Therapeutics Market: Global Leaders Share Views on Permanency and Adoption published…
